Among HAART naïve subjects, mortality was significantly higher for those with unknown baseline CD4 cell count (p = 0.001) and who had disseminated TB (p = 0.04), whereas HAART use during TB treatment (p = 0.02) was associated with longer survival. Here, CD4 is linked to tuberculosis.